Topical pimecrolimus 1% cream in the treatment of seborrheic dermatitis.

about

High Staphylococcus epidermidis Colonization and Impaired Permeability Barrier in Facial Seborrheic Dermatitis.

P2860

Q40132123-B03D62CC-6472-48D7-BC22-07F9AD986855

P2860

Topical pimecrolimus 1% cream in the treatment of seborrheic dermatitis.

Item

http://www.wikidata.org/entity/Q38084638

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Topical pimecrolimus 1% cream in the treatment of seborrheic dermatitis.

@en

type

Item

label

Topical pimecrolimus 1% cream in the treatment of seborrheic dermatitis.

@en

prefLabel

Topical pimecrolimus 1% cream in the treatment of seborrheic dermatitis.

@en

P1476

Topical pimecrolimus 1% cream in the treatment of seborrheic dermatitis

@en

P2093

Grace K Kim

http://www.w3.org/2001/XMLSchema#string

James Del Rosso

http://www.w3.org/2001/XMLSchema#string

P2860

Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients

Alcohol-induced application site erythema after topical immunomodulator use and its inhibition by aspirin

A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology

Pimecrolimus: a review of pre-clinical and clinical data.

Cancer concerns with topical immunomodulators in atopic dermatitis: overview of data and recommendations to clinicians.

Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis.

Management of seborrheic dermatitis and pityriasis versicolor.

Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.

Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus.

The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force.

P304

29-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23441238

http://www.w3.org/2001/XMLSchema#string

P932

3579486

http://www.w3.org/2001/XMLSchema#string

Topical pimecrolimus 1% cream in the treatment of seborrheic dermatitis.

about

P2860

P2860

Topical pimecrolimus 1% cream in the treatment of seborrheic dermatitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932